Data processing: financial – business practice – management – or co – Automated electrical financial or business practice or... – Health care management
Reexamination Certificate
2011-06-21
2011-06-21
O'Connor, Gerald J. (Department: 3686)
Data processing: financial, business practice, management, or co
Automated electrical financial or business practice or...
Health care management
C705S004000
Reexamination Certificate
active
07966196
ABSTRACT:
A computer-implemented system and method for administering a drug registry database generates a display of a plurality of new drug/comparator drug pairings, wherein each new drug is added to the database when a threshold number of healthcare claims for the new drug have been received. Upon receiving a selection of a new drug/comparator drug pairing, and filter parameters input by a user, an analysis engine searches the healthcare claims stored in the database to identify a first and second group of patients satisfying the filter parameters input by the user; wherein the first group includes patients with claim data indicating use of the new drug and the second group includes patients with claim data indicating use of the comparator drug. The analysis engine further identifies a comparative occurrence of one or more existing medical conditions or new medical conditions in the first and second groups of patients and calculates a probability value indicating a relative likelihood that a patient taking the new drug will have each of the one or more new or existing medical conditions in comparison to a likelihood that a patient taking the comparator drug will have each of the one or more new or existing medical conditions. A user interface displays each new or existing medical condition and the probability value for the new drug and the comparator drug in accordance with one or more report parameters entered by the user.
REFERENCES:
patent: 5845255 (1998-12-01), Mayaud
patent: 6219674 (2001-04-01), Classen
patent: 6529892 (2003-03-01), Lambert
patent: 6584472 (2003-06-01), Classen
patent: 7461006 (2008-12-01), Gogolak
patent: 2002/0083080 (2002-06-01), Classen
patent: 2002/0183965 (2002-12-01), Gogolak
patent: 2003/0046110 (2003-03-01), Gogolak
patent: 2005/0079511 (2005-04-01), Mandema et al.
patent: 2006/0111847 (2006-05-01), Pearson et al.
patent: 2006/0195418 (2006-08-01), Classen
patent: 2007/0033075 (2007-02-01), Hoffman et al.
patent: 2310060 (1997-08-01), None
patent: WO 02/088901 (2002-11-01), None
patent: WO 02/089015 (2002-11-01), None
patent: WO2005031509 (2005-04-01), None
Graham, David J., et al., “Incidence of Hospitalized Rhabdomyolosis in Patients Treated with Lipid-Lowering Drugs” (JAMA, Dec. 1, 2004, vol. 292, No. 21, pp. 2585-2590).
Geraud, G., et al., “Tolerability and safety of frovatripan with short-and long-term use of treatment of migraine and in comparison with sumatripan” (Headache, Apr. 2002, 42 Suppl. 2:S93-9).
Layton, Deborah, et al. “Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?” (Eur. J. Clin. Pharmacol. (2001) 57: 167-176).
Enger, Cheryl, et al. “Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States” (Pharmacoepidemiology and Drug Satety 2002; 11: 477-486.
Walker, “Pattern recognition in health insurance claims databases,”Pharmacoepidemiology and Drug Safety, 2001; 10: 393-397.
Smalley et al., “Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action,”Journal of the American Medical Association, vol. 284, No. 23 (Dec. 20, 2000). 3036-3039.
Walker et al., “Patterns of Interchange in the Dispensing of Non-Steroidal Anti-Inflammatory Drugs,”J. Clin. Epidemiol., vol. 45, No. 2 (1992). 187-195.
Jick et al., “Postmarketing Follow-up,”Journal of the American Medical Association, vol. 242, No. 21 (Nov. 23, 1979). 2310-2314.
Dorsey & Whitney LLP
Ingenix Inc.
Nguyen Hiep V.
O'Connor Gerald J.
Padmanabhan Devan V.
LandOfFree
System and method for early identification of safety... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for early identification of safety..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for early identification of safety... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691757